The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCSL.L Regulatory News (CCSL)

  • There is currently no data for CCSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Apr 2019 12:00

RNS Number : 4407V
Chenavari Capital Solutions Limited
08 April 2019
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Chenavari Capital Solutions Ltd

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

X

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Weiss Asset Management LP

City and country of registered office (if applicable)

Wilmington, Delaware, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

Brookdale International Partners, L.P., Brookdale Global Opportunity Fund

City and country of registered office (if applicable)

Brookdale International Partners, L.P.: New York, NY, USA

Brookdale Global Opportunity Fund: Grand Cayman, Cayman Islands

5. Date on which the threshold was crossed or reachedvi:

Apr-02-2019, Apr-03-2019

6. Date on which issuer notified (DD/MM/YYYY):

Apr-05-2019

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

13.41 %

0.28%

13.69 %

52,614,517

Position of previous notification (if

applicable)

4.89 %

0.28 %

5.17 %

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GG00BHR3GH97

7,053,032

13.41 %

SUBTOTAL 8. A

7,053,032

13.41 %

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

CFD

N/A

N/A

Cash Settlement

148,247

0.28%

SUBTOTAL 8.B.2

148,247

0.28%

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Weiss Asset Management LP

Brookdale International Partners, L.P.

9.26 %

0.19%

9.45 %

Weiss Asset Management LP

Brookdale Global Opportunity Fund

Below 5.0%

Below 5.0%

Below 5.0%

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

Weiss Asset Management LP is the Investment Manager to Brookdale Global Opportunity Fund and Brookdale International Partners, L.P.

 

Place of completion

Boston, USA

Date of completion

Apr-05-2019

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUGURACUPBUBR
Date   Source Headline
25th Apr 20174:15 pmRNSFactsheet Available
21st Apr 201710:00 amRNSNet Asset Value(s)
21st Apr 201710:00 amRNSDividend Declaration
4th Apr 20175:00 pmRNSQuarterly Investor Call
3rd Apr 20177:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20175:00 pmRNSChange of Committee Membership
28th Mar 20175:02 pmRNSFactsheet Available - February 2017
28th Mar 20174:00 pmRNSResult of AGM
20th Mar 20173:30 pmRNSCorrection - Partial Compulsory Redemption
17th Mar 20174:30 pmRNSPartial Compulsory Redemption of Shares
17th Mar 20177:00 amRNSNet Asset Value(s)
15th Mar 20173:00 pmRNSResult of EGM
28th Feb 20175:00 pmRNSFactsheet Available - January 2017
24th Feb 201711:30 amRNSNet Asset Value(s)
16th Feb 20172:00 pmRNSNotice of GM
10th Feb 20175:15 pmRNSTransaction in Own Shares
8th Feb 20175:00 pmRNSNotice of AGM
31st Jan 20174:30 pmRNSFactsheet Available - December 2016
24th Jan 20179:53 amRNSQuarterly Investor Call
20th Jan 20175:00 pmRNSAnnual Financial Report
20th Jan 20172:30 pmRNSDividend Declaration
20th Jan 20172:00 pmRNSNet Asset Value(s)
12th Jan 20177:00 amRNSTransaction in Own Shares
6th Jan 20174:00 pmRNSQuarterly Investor Call
23rd Dec 20161:45 pmRNSFactsheet Available - November 2016
16th Dec 20162:30 pmRNSNet Asset Value(s)
13th Dec 20167:00 amRNSReturn of Capital
23rd Nov 20164:40 pmRNSFactsheet Available - October 2016
21st Nov 20165:15 pmRNSNet Asset Value(s)
27th Oct 20167:00 amRNSDividend Declaration
26th Oct 20162:00 pmRNSFactsheet Available - September 2016
21st Oct 20163:00 pmRNSNet Asset Value(s)
23rd Sep 20163:00 pmRNSFactsheet Available - August 2016
15th Sep 20164:15 pmRNSNet Asset Value(s)
13th Sep 20161:30 pmRNSNotification of Major Interest in Shares
23rd Aug 20165:00 pmRNSFactsheet Available - July 2016
16th Aug 20164:30 pmRNSNet Asset Value(s)
2nd Aug 20163:30 pmRNSNotification of Major Interest in Shares
28th Jul 20163:30 pmRNSDividend Declaration
21st Jul 20165:00 pmRNSFactsheet Available - June 2016
18th Jul 20161:00 pmRNSNet Asset Value(s)
28th Jun 201612:30 pmRNSBrexit Impact
27th Jun 201612:00 pmRNSFactsheet Available - May 2016
16th Jun 20163:00 pmRNSNet Asset Value(s)
27th May 20167:00 amRNSPrimary Investment
25th May 20167:00 amRNSHalf-year Report
23rd May 20162:00 pmRNSFactsheet Available - April 2016
18th May 201612:41 pmRNSHolding(s) in Company
17th May 20163:00 pmRNSNet Asset Value(s)
21st Apr 20167:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.